Table 1 Study groups characteristics
Characteristics | N | Percent (%) | |
|---|---|---|---|
NSCLC patients | |||
N | 50 | 100 | |
Median age (years), range | 65 (39–84) | ||
Sex | |||
Male | 32 | 64 | |
Female | 18 | 36 | |
Histology (WHO) | |||
ADC | 24 | 48 | |
SCC | 22 | 44 | |
Other | 4 | 8 | |
Stage (TNM) | |||
I | 22 | 44 | |
II | 20 | 40 | |
IIIA | 8 | 16 | |
COPD patients | |||
N | 34 | 100 | |
Median age (years), range | 69 (41–82) | ||
Sex | |||
Male | 23 | 67.6 | |
Female | 11 | 32.4 | |
Asthma patients | |||
N | 32 | 100 | |
Median age (years), range | 55 (23–80) | ||
Sex | |||
Male | 13 | 40.6 | |
Female | 19 | 59.4 | |
Sarcoidosis patients | |||
N | 35 | 100 | |
Median age (years), range | 44 (29–65) | ||
Sex | |||
Male | 19 | 54.3 | |
Female | 16 | 45.7 | |
Healthy controls | |||
N | 40 | 100 | |
Median age (years), range | 40.5 (24–66) | ||
Sex | |||
Male | 13 | 32.5 | |
Female | 27 | 67.5 | |